Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318202 | SCV000851459 | uncertain significance | Inborn genetic diseases | 2017-09-22 | criteria provided, single submitter | clinical testing | The p.T394A variant (also known as c.1180A>G), located in coding exon 9 of the GABRA1 gene, results from an A to G substitution at nucleotide position 1180. The threonine at codon 394 is replaced by alanine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |